Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review

Omega-3 polyunsaturated fatty acids (PUFAs) have well established anti-cancer properties. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are among this biologically active family of macromolecules for which various anti-cancer effects have been explained. These PUFAs have a high safety profile and can induce apoptosis and inhibit growth of cancer cells both in vitro and in vivo, following a partially selective manner. They also increase the efficacy of chemotherapeutic agents by increasing the sensitivity of different cell lines to specific anti-neoplastic drugs. Various mechanisms have been proposed for the anti-cancer effects of these omega-3 PUFAs; however, the exact mechanisms still remain unknown. While numerous studies have investigated the effects of DHA and EPA on solid tumors and the responsible mechanisms, there is no consensus regarding the effects and mechanisms of action of these two FAs in hematological malignancies. Here, we performed a systematic review of the beneficial effects of EPA and DHA on hematological cell lines as well as the findings of related in vivo studies and clinical trials. We summarize the key underlying mechanisms and the therapeutic potential of these PUFAs in the treatment of hematological cancers. Differential expression of apoptosis-regulating genes and Glutathione peroxidase 4 (Gp-x4), varying abilities of different cancerous and healthy cells to metabolize EPA into its more active metabolites and to uptake PUFAS are among the major factors that determine the sensitivity of cells to DHA and EPA. Considering the abundance of data on the safety of these FAs and their proven anti-cancer effects in hematological cell lines and the lack of related human studies, further research is warranted to find ways of exploiting the anticancer effects of DHA and EPA in clinical settings both in isolation and in combination with other therapeutic regimens.

[1]  P. Calder,et al.  Oral fish oil positively influences nutritional‐inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long‐term survival: a randomised clinical trial , 2017, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[2]  M. Abdollahi,et al.  Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases , 2017, Ageing Research Reviews.

[3]  M. Abdollahi,et al.  Melatonin as a multifunctional anti‐cancer molecule: Implications in gastric cancer , 2017, Life sciences.

[4]  É. Rousseau,et al.  Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: Anti-inflammatory and anti-proliferative effects. , 2016, European journal of pharmacology.

[5]  Hyeyoung Kim,et al.  Docosahexaenoic Acid Induces Oxidative DNA Damage and Apoptosis, and Enhances the Chemosensitivity of Cancer Cells , 2016, International journal of molecular sciences.

[6]  Jacob J. Kinnun,et al.  Membrane Disordering by Eicosapentaenoic Acid in B Lymphomas Is Reduced by Elongation to Docosapentaenoic Acid as Revealed with Solid-State Nuclear Magnetic Resonance Spectroscopy of Model Membranes. , 2016, The Journal of nutrition.

[7]  M. Callanan,et al.  Docosahexaenoic Acid Induces Apoptosis in Primary Chronic Lymphocytic Leukemia Cells , 2015, Hematology reports.

[8]  R. Paulson,et al.  Chemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia , 2015, Cancer Prevention Research.

[9]  J. Garssen,et al.  Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells. , 2014, The Journal of nutritional biochemistry.

[10]  K. Maki,et al.  A new, microalgal DHA- and EPA-containing oil lowers triacylglycerols in adults with mild-to-moderate hypertriglyceridemia. , 2014, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  Y. Jeong,et al.  Eicosapentaenoic Acid and Docosahexaenoic Acid Suppress Th2 Cytokine Expression in RBL-2H3 Basophilic Leukemia Cells , 2014 .

[12]  C. Riccardi,et al.  Eicosapentaenoic Acid Activates RAS/ERK/C/EBPβ Pathway through H-Ras Intron 1 CpG Island Demethylation in U937 Leukemia Cells , 2014, PLoS ONE.

[13]  M. Pyo,et al.  Eicosapentaenoic acid and docosahexaenoic acid suppress Th2 cytokine expression in RBL-2H3 basophilic leukemia cells. , 2014, Journal of medicinal food.

[14]  M. Glibetić,et al.  Distribution of plasma fatty acids is associated with response to chemotherapy in non-Hodgkin’s lymphoma patients , 2013, Medical Oncology.

[15]  Chih-Chiang Chien,et al.  Arachidonic acid enhances TPA-induced differentiation in human leukemia HL-60 cells via reactive oxygen species-dependent ERK activation. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  J. Fahrmann,et al.  Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine , 2013, Lipids in Health and Disease.

[17]  E. Nunes,et al.  Effects of omega-3 fatty acids on regulatory T cells in hematologic neoplasms , 2013, Revista brasileira de hematologia e hemoterapia.

[18]  D. Tsikas,et al.  Dietary eicosapentaenoic acid (EPA) to produce antileukemic cyclopentenone prostaglandin J3? , 2012, Blood.

[19]  P. Calder.  Mechanisms of action of (n-3) fatty acids. , 2012, The Journal of nutrition.

[20]  R. Siddiqui,et al.  Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. , 2011, BioFactors.

[21]  P. di Nardo,et al.  Eicosapentaenoic Acid Demethylates a Single CpG That Mediates Expression of Tumor Suppressor CCAAT/Enhancer-binding Protein δ in U937 Leukemia Cells* , 2011, The Journal of Biological Chemistry.

[22]  S. Frame,et al.  Safety assessment of EPA-rich triglyceride oil produced from yeast: genotoxicity and 28-day oral toxicity in rats. , 2011, Regulatory toxicology and pharmacology : RTP.

[23]  M. Glibetić,et al.  Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma , 2010, Annals of Hematology.

[24]  E. Lien.  Toxicology and safety of DHA. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[25]  F. Erbey,et al.  The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy‐related weight loss in children , 2009, Pediatric blood & cancer.

[26]  S. Serini,et al.  Antineoplastic Effects of N-3 Polyunsaturated Fatty Acids in Combination With Drugs and Radiotherapy: Preventive and Therapeutic Strategies , 2009, Nutrition and cancer.

[27]  H. Krokan,et al.  The Antiproliferative Effect of EPA in HL60 Cells is Mediated by Alterations in Calcium Homeostasis , 2009, Lipids.

[28]  C. Schacky,et al.  Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? , 2008, Current opinion in clinical nutrition and metabolic care.

[29]  C. von Schacky.  Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? , 2008, Current opinion in clinical nutrition and metabolic care.

[30]  R. Curi,et al.  Docosahexaenoic acid enhances the toxic effect of imatinib on Bcr-Abl expressing HL-60 cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[31]  Aude Plé,et al.  Docosahexaenoic Acid Induces Increases in [Ca2+]i via Inositol 1,4,5-Triphosphate Production and Activates Protein Kinase Cγ and -δ via Phosphatidylserine Binding Site: Implication in Apoptosis in U937 Cells , 2007, Molecular Pharmacology.

[32]  P. García-Peris,et al.  N-3 fatty acids, cancer and cachexia: a systematic review of the literature. , 2007, The British journal of nutrition.

[33]  W. Ding,et al.  Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid–induced cytotoxicity , 2007, Molecular Cancer Therapeutics.

[34]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[35]  Megan Brown,et al.  Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1. , 2007, Blood.

[36]  B. Ross,et al.  Antioxidant modulation of oxidant-stimulated uptake and release of arachidonic acid in eicosapentaenoic acid-supplemented human lymphoma U937 cells. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[37]  R. Palmiter,et al.  Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells , 2006, Molecular Cancer Therapeutics.

[38]  L. Jenski,et al.  Docosahexaenoic acid increases permeability of lipid vesicles and tumor cells , 1993, Lipids.

[39]  H. Yoshida,et al.  Inhibitory effect of conjugated eicosapentaenoic acid on mammalian DNA polymerase and topoisomerase activities and human cancer cell proliferation. , 2005, Biochemical pharmacology.

[40]  B. Ross,et al.  Differential effects of eicosapentaenoic and docosahexaenoic acids upon oxidant-stimulated release and uptake of arachidonic acid in human lymphoma U937 cells. , 2005, Pharmacological research.

[41]  Takuji Tanaka,et al.  Docosahexaenoic acid-containing phosphatidylethanolamine enhances HL-60 cell differentiation by regulation of c-jun and c-myc expression , 2005, Molecular and Cellular Biochemistry.

[42]  Y. Nakagawa,et al.  Involvement of hydroperoxide in mitochondria in the induction of apoptosis by the eicosapentaenoic acid , 2005, Free radical research.

[43]  M. Muscaritoli,et al.  Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia , 2005, Cancer.

[44]  Y. Nakagawa,et al.  Role of calcium-induced mitochondrial hydroperoxide in induction of apoptosis of RBL2H3 cells with eicosapentaenoic acid treatment , 2005, Free radical research.

[45]  N. Das,et al.  Antiproliferative effect of polyunsaturated fatty acids and interleukin-2 on normal and abnormal human lymphocytes , 1994, Experientia.

[46]  M. Moyad.  An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II. , 2005, Urologic oncology.

[47]  E. Roth,et al.  Enhancement of arsenic trioxide‐mediated apoptosis using docosahexaenoic acid in arsenic trioxide‐resistant solid tumor cells , 2004, International journal of cancer.

[48]  V. Ooi,et al.  Docosahexaenoic acid modulates different genes in cell cycle and apoptosis to control growth of human leukemia HL-60 cells. , 2004, International journal of oncology.

[49]  K. Utsumi,et al.  Docosahexaenoic Acid Induces Apoptosis via the Bax-Independent Pathway in HL-60 Cells , 2004, Bioscience, biotechnology, and biochemistry.

[50]  K. Moutairou,et al.  Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T‐cells , 2003, British journal of pharmacology.

[51]  N. Aaronson,et al.  Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial , 2003, Gut.

[52]  E. Roth,et al.  Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells. , 2003, Blood.

[53]  R. Chapkin,et al.  Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. , 2003, The Journal of nutrition.

[54]  D. Horrobin,et al.  The effects on plasma, red cell and platelet fatty acids of taking 12 g/day of ethyl-eicosapentaenoate for 16 months: dihomogammalinolenic, arachidonic and docosahexaenoic acids and relevance to Inuit metabolism. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[55]  D. Horrobin,et al.  A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels. , 2003, Medical hypotheses.

[56]  L. Jenski,et al.  Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. , 2003, The Biochemical journal.

[57]  C. Drevon,et al.  Eicosapentaenoic acid-induced apoptosis depends on acyl CoA-synthetase , 2003, Lipids.

[58]  M. Puertollano,et al.  Polyunsaturated fatty acids induce cell death in YAC-1 lymphoma by a caspase-3-independent mechanism. , 2003, Anticancer research.

[59]  M. C. Cha,et al.  Dietary Docosahexaenoic Acid Levels Influence the Outcome of Arabinosylcytosine Chemotherapy in L1210 Leukemic Mice , 2002, Nutrition and cancer.

[60]  B. Enderson,et al.  Eicosapentaenoic acid and γ-linolenic acid induce apoptosis in HL-60 cells , 2002 .

[61]  D. Grobbee,et al.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.

[62]  C. Drevon,et al.  Eicosapentaenoic acid promotes apoptosis in Ramos cells via activation of caspase-3 and -9 , 2002, Lipids.

[63]  L. Jenski,et al.  Prevention of docosahexaenoic acid-induced cytotoxicity by phosphatidic acid in Jurkat leukemic cells: the role of protein phosphatase-1. , 2001, Biochimica et biophysica acta.

[64]  W. Waldhäusl,et al.  Polyunsaturated Eicosapentaenoic Acid Displaces Proteins from Membrane Rafts by Altering Raft Lipid Composition* , 2001, The Journal of Biological Chemistry.

[65]  T. Utsumi,et al.  Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. , 2001, Biochemical pharmacology.

[66]  C. Drevon,et al.  Necrosis and apoptosis in lymphoma cell lines exposed to eicosapentaenoic acid and antioxidants , 2001, Lipids.

[67]  Kristiana D. Neff,et al.  Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process. , 2001, Biochimica et biophysica acta.

[68]  K. Erickson,et al.  Regulation of cellular differentiation and apoptosis by fatty acids and their metabolites. , 2001, Nutrition research.

[69]  J. Wan,et al.  Induction of apoptosis by dietary polyunsaturated fatty acids in human leukemic cells is not associated with DNA fragmentation. , 2000, International journal of oncology.

[70]  B. Tan,et al.  Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines. , 2000, Life sciences.

[71]  G. Ogilvie,et al.  Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma , 2000, Cancer.

[72]  C. Drevon,et al.  Uptake and activation of eicosapentaenoic acid are related to accumulation of triacylglycerol in Ramos cells dying from apoptosis. , 2000, Journal of lipid research.

[73]  M. Tsuchida,et al.  Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice , 2000, Lipids.

[74]  J. Wan,et al.  Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. , 1999, Cancer letters.

[75]  C. Jan,et al.  Multiple effects of econazole on calcium signaling: depletion of thapsigargin-sensitive calcium store, activation of extracellular calcium influx, and inhibition of capacitative calcium entry. , 1999, Biochimica et biophysica acta.

[76]  C. Drevon,et al.  Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid. , 1998, The Biochemical journal.

[77]  A. Benedetti,et al.  On the mechanism of action of econazole, the capacitative calcium inflow blocker. , 1998, Biochemical and biophysical research communications.

[78]  C. Drevon,et al.  Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids , 1998, Leukemia.

[79]  E. E. Williams,et al.  Docosahexaenoic acid (DHA) alters the structure and composition of membranous vesicles exfoliated from the surface of a murine leukemia cell line. , 1998, Biochimica et biophysica acta.

[80]  E. Kishida,et al.  Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. , 1998, Biochimica et biophysica acta.

[81]  U. Das,et al.  Cytotoxic action of alpha-linolenic and eicosapentaenoic acids on myeloma cells in vitro. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.

[82]  M. Tisdale,et al.  Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. , 1996, Nutrition.

[83]  C. Drevon,et al.  Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells. , 1994, Blood.

[84]  J. Kinsella,et al.  Effects of polyunsaturated fatty acids on the efficacy of antineoplastic agents toward L5178Y lymphoma cells. , 1993, Biochemical pharmacology.

[85]  L. Brunton,et al.  Differential effects of omega-3 fish oils on protein kinase activities in vitro. , 1991, The American journal of physiology.

[86]  L L van Deenen,et al.  The properties of polyunsaturated lecithins in monolayers and liposomes and the interactions of these lecithins with cholesterol. , 1972, Biochimica et biophysica acta.